These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3002289)

  • 1. [Development of a method for the study of drugs which inhibit phospholipase A2].
    Alcaraz MJ
    Arch Farmacol Toxicol; 1985 Aug; 11(2):73-8. PubMed ID: 3002289
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
    Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
    Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of anterior pituitary prolactin release by melittin, an activator of phospholipase A2.
    Grandison L
    Endocrinology; 1984 Jan; 114(1):1-7. PubMed ID: 6418521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C.
    AbuBakar S; Boldogh I; Albrecht T
    Biochem Biophys Res Commun; 1990 Jan; 166(2):953-9. PubMed ID: 2154225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phospholipase A2 in vitro by some anti-hypoxic drugs.
    Nikolov R; Koburova K
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):429-31. PubMed ID: 6436598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
    Filippov A; Skatova G; Porotikov V; Kobrinsky E; Saxon M
    Gen Physiol Biophys; 1989 Apr; 8(2):113-8. PubMed ID: 2777057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of catecholamine release from adrenal chromaffin cells by phospholipase A2- and lipoxygenase-inhibitors.
    Sasakawa N; Yamamoto S; Kumakura K; Kato R
    Jpn J Pharmacol; 1983 Oct; 33(5):1077-80. PubMed ID: 6417385
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraventricular injections of drugs which inhibit phospholipase A2 suppress fever in rabbits.
    Cranston WI; Hellon RF; Mitchell D; Townsend Y
    J Physiol; 1983 Jun; 339():97-105. PubMed ID: 6887041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contamination of commercial preparations of calmodulin by phospholipase A2.
    Hope WC; Welton AF; Swislocki NI
    Biochim Biophys Acta; 1986 Mar; 881(1):107-12. PubMed ID: 3004596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E; Gougat J; Navarro J; Delahayes JF
    J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of phospholipase A2 action and arachidonic acid metabolism in angiotensin II-mediated aldosterone secretion.
    Kojima I; Kojima K; Rasmussen H
    Endocrinology; 1985 Sep; 117(3):1057-66. PubMed ID: 3926464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action of an anti-inflammatory steroid on changes in vascular permeability (II). Evaluation of its action as a phospholipase A2 inhibitor].
    Tajima M; Maruyama S; Ichikawa M; Kim T; Arai T; Sato S
    Josai Shika Daigaku Kiyo; 1984; 13(1):60-7. PubMed ID: 6441611
    [No Abstract]   [Full Text] [Related]  

  • 14. Phospholipase A2 inhibitors. Differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide.
    Erman A; Azuri R; Raz A
    Biochem Pharmacol; 1983 Jul; 32(13):2083-7. PubMed ID: 6870935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphlogistic effectiveness of combinations of inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases of the arachidonic acid cascade].
    Bekemeier H; Hirschelmann R
    Pharmazie; 1986 Apr; 41(4):260-2. PubMed ID: 3088612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of arachidonic acid release by enzyme(s) of rat brain cortex.
    Samochocki M; Strosznajder J
    Acta Biochim Pol; 1990; 37(1):93-7. PubMed ID: 2128431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of the phospholipases in the mitogenic actions of prolactin (PRL) on Nb2 node lymphoma cells.
    Ofenstein JP; Rillema JA
    Proc Soc Exp Biol Med; 1987 Jun; 185(2):147-52. PubMed ID: 3106986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of diacylglycerol-stimulated intracellular phospholipases by phospholipids with a phosphocholine-containing polar group. A possible physiological role for sphingomyelin.
    Dawson RM; Hemington N; Irvine RF
    Biochem J; 1985 Aug; 230(1):61-8. PubMed ID: 2996496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone directly inhibits snake venom phospholipase A.
    Kato N; Halprin KM; Matsuo S; Taylor JR
    Biochem Biophys Res Commun; 1985 Jul; 130(2):761-7. PubMed ID: 4026856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dantrolene and mepacrine antagonize the hemolysis of human red blood cells by halothane and bee venom phospholipase A2.
    Fletcher JE; Kistler P; Rosenberg H; Michaux K
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):410-9. PubMed ID: 3660410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.